← All trials
NCT05256069
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2023
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Feb 25, 2022
- Last posted
- Nov 14, 2022
- Enrollment
- 35
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of MissouriLead sponsor
- American Heart AssociationCollaborator
- University of MissouriOverall official - principal investigator
- University of MissouriReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.